Long-term mortality of coronavirus disease 2019 critically ill patients that required percutaneous tracheostomy in Chile: A multicenter cohort study
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leads to mechanical ventilation (MV) in approximately 20% of hospitalized patients. Tracheostomy expedites weaning of respiratory support. Moreover, there is a paucity of data regarding long-term outcomes of tracheostomized coronavirus disease 2019 (COVID-19) patients. The objective of this study was to describe 1-year mortality in a cohort of COVID-19 critically ill patients who required percutaneous tracheostomy in Chile and to assess the impact of age on outcomes. Methods: A multicenter prospective observational study was conducted in 4 hospitals in Chile between March 2020 and July 2021. Patients with confirmed SARS-CoV-2 infection connected to MV and required percutaneous tracheostomy were included. Baseline data, relevant perioperative and long-term outcomes, such as 1-year mortality, MV duration, intensive care unit (ICU), and hospital length of stay were registered. Patients were dichotomized according to age group (< and ≥ 70 years). Univariate and multivariate logistic regressions were performed to identify predictors of 1-year mortality. Results: Of 1319 COVID-19 ventilated critically ill patients, 23% (304) required a percutaneous tracheostomy. One-year mortality of the study group was 25% (20.2%-30.3%). ICU and hospital length of stay (LOS) were of 37 (27-49) and 52 (40-72) days. One-year mortality was higher in patients ≥ 70 years (36.9% vs. 21.2%, P = 0.012). Multivariate analysis confirmed age and baseline sequential organ failure assessment (SOFA) score as independent predictors, while time from intubation to tracheostomy was not. Conclusion: In COVID-19 critically ill patients who required percutaneous tracheostomy in Chile, the 1-year mortality rate was 25%, with a relevant impact of age on outcomes. An appropriate patient selection likely accounted for the low mortality rate. Future studies should confirm these results.
Authors
- Ronald Pairumani
- Francisco Abbott
- Antonia Pastoré
- Sebastián Bravo (ORCID: https://orcid.org/0000-0003-0998-8433)
- Sebastián Reyes
- Eduardo Kattan (ORCID: https://orcid.org/0000-0002-1997-6893)
- Guillermo Bugedo (ORCID: https://orcid.org/0000-0001-7527-6202)
- F. González (ORCID: https://orcid.org/0000-0001-6376-4647)
- José Escalona (ORCID: https://orcid.org/0009-0008-0766-4850)
- Magdalena Vera (ORCID: https://orcid.org/0000-0002-2969-3408)
- Rodrigo Ulloa-Morrison
- Jan Bakker
- Pablo Navarrete
- Roselyn Noguera
- Felipe Valle
- Javiera Espinoza
- Milan Bozinovic
Institutions
- Pontificia Universidad Católica de Chile (CL)
- Columbia University Irving Medical Center (US)
- Erasmus MC (NL)
- Hospital Barros Luco-Trudeau (CL)
- Hospital del Salvador (CL)
- Pulmonary and Allergy Associates (US)
- Hospital Las Higueras (CL)
Publication Details
- Journal
- Journal of Translational Critical Care Medicine
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1097/jtccm-d-24-00023
- Primary Topic
- Tracheal and airway disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00